Author Topic: (ACTRIMS/ECTRIMS) Masitinib for progressive MS, maybe even nonactive SPMS  (Read 7 times)

0 Members and 0 Guests are viewing this topic.

Offline agate

  • Administrator
  • *****
  • Posts: 8629
  • MS diagnosed 1980
  • Location: Pacific Northwest
From MedPage Today (September 14, 2014), "Masitinib shows positive signs in progressive MS," a report from the recent ACTRIMS/ECTRIMS meeting:

Of special note is this part of the article:


[/size]The drug, which specifically downregulates mast cells and microglia, appeared to slow disability progression in people with primary progressive multiple sclerosis (PPMS) and non-active secondary progressive MS (SPMS) over 2 years, reported Patrick Vermersch, PhD, of University of Lille in France, at MS Virtual 2020, the joint ACTRIMS-ECTRIMS meeting.[/size]
[/size]Point estimates consistently supported efficacy, but not all were significant.[/color]
[/size]This is the first time that a drug targeting innate immune cells -- as opposed to targeting adaptive immune cells like B cells and T cells -- has shown positive results in PPMS and non-active SPMS, Vermersch noted.[/color]

[/size]Emphasis added. I have never before seen an MS drug that is reported as indicated for non-active SPMS.[/color]

[/size][size=78%]Masitinib was mentioned in this thread, in the post dated 11/21/14--and it seems it has been used up to now in veterinary practice:[/size]
MS Speaks--online for 14 years

SPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010.


Related Topics

  Subject / Started by Replies Last post
3 Replies
Last post December 07, 2017, 02:46:33 pm
by agate
0 Replies
Last post March 11, 2020, 09:40:52 pm
by agate
0 Replies
Last post September 11, 2020, 09:40:14 pm
by agate
0 Replies
Last post September 14, 2020, 12:59:37 pm
by agate
0 Replies
Last post September 28, 2020, 04:17:59 pm
by agate